Month: January 2019

Intact Vascular Announces Presentations at LINC 2019 Annual Meeting

Presentations Showcase the Importance of Treating Post-Angioplasty Dissections January 14, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured at the annual Leipzig Interventional Course (LINC) in Leipzig, Germany on Tuesday, January …

Intact Vascular Announces Presentations at LINC 2019 Annual Meeting Read More »

Intact Vascular Announces Launch of the Tack Endovascular System® in the EU and First Commercial Use in Germany

January 7, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the first commercial use of its Tack Endovascular System® in multiple hospitals within Germany. A novel therapy for dissection repair following balloon angioplasty, the Tack® implant is a first-of-its kind device for patients with …

Intact Vascular Announces Launch of the Tack Endovascular System® in the EU and First Commercial Use in Germany Read More »

Intact Vascular Announces Enrollment Completion of TOBA II BTK Clinical

First-of-its-kind study designed to demonstrate safety and efficacy of the Tack Endovascular System® in treating post-PTA dissections below the knee. January 2, 2019 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced its Tack Optimized Balloon Angioplasty II BTK (TOBA II BTK) clinical trial successfully completed enrollment, ahead of schedule.

Scroll to Top
Intact Vascular uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this.